Ajax-Loading

Sino Biopharmaceutical Ltd - End Period Cash Flow

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "End-Period-Cash-Flow" stands at -1.52 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 03/31/2025.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.3824 Billion Hong Kong Dollars compared to the value the year prior.
The 1 year change is -0.3824 Billion Hong Kong Dollars.
The 3 year change is -1.32 Billion Hong Kong Dollars.
The 5 year change is -4.18 Billion Hong Kong Dollars.
The 10 year change is -3.84 Billion Hong Kong Dollars.

The Serie's long term average value is 3.24 Billion Hong Kong Dollars. It's latest available value, on 03/31/2025, is -4.76 Billion Hong Kong Dollars lower, compared to it's long term average value.
The Serie's change in Hong Kong Dollars from it's minimum value, on 09/30/2024, to it's latest available value, on 03/31/2025, is +1.52 Billion.
The Serie's change in Hong Kong Dollars from it's maximum value, on 12/31/2022, to it's latest available value, on 03/31/2025, is -14.47 Billion.

End Period Cash Flow for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - End Period Cash Flow905,699,262,464.00
LogoJohnson & Johnson - End Period Cash Flow486,508,953,600.00
LogoAbbVie Inc - End Period Cash Flow399,570,305,024.00
LogoRoche Holding AG - End Period Cash Flow317,433,206,677.55
LogoAstraZeneca PLC - End Period Cash Flow280,205,508,085.11